FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (SOFIE Co.)

View source ↗

Summary

FDA approved the original application for Fludeoxyglucose F-18 (FDG F-18) from SOFIE Co., a radiopharmaceutical used in PET imaging for diagnostic purposes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F 18 (FLUDEOXYGLUCOSE F-18)